Compare LODE & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LODE | ORGO |
|---|---|---|
| Founded | 1999 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.9M | 166.0M |
| IPO Year | 2004 | 2016 |
| Metric | LODE | ORGO |
|---|---|---|
| Price | $1.76 | $0.99 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | ★ 1.5M | 601.6K |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 63.55 | ★ 1600.00 |
| EPS | ★ N/A | N/A |
| Revenue | $1,553,796.00 | ★ $564,169,000.00 |
| Revenue This Year | $303.79 | N/A |
| Revenue Next Year | $410.04 | $37.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $1.76 | $1.10 |
| 52 Week High | $4.98 | $7.08 |
| Indicator | LODE | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 17.98 | 18.64 |
| Support Level | N/A | N/A |
| Resistance Level | $3.32 | $2.69 |
| Average True Range (ATR) | 0.11 | 0.06 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 3.48 | 0.00 |
Comstock Inc commercializes technologies that convert underutilized waste and natural resources into clean energy and supporting products, including electrification, metals, and minerals from end-of-life solar panels. Its subsidiary focuses on producing renewable fuels from waste, energy crops, and woody biomass, supported by facilities in Wisconsin, pilot farms, a biorefinery site in Tulsa, and solar panel recycling operations in Nevada. The Company operates through two high-growth segments and a corporate segment, with its activities grouped into Metals, which generates the majority of revenue, Fuels, Mining, Strategic Investments, and Corporate Services.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.